PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $21,340,000 | -15.4% | 433,834 | +16.0% | 0.10% | -33.1% |
| Q4 2020 | $25,211,000 | +19.9% | 373,875 | -15.9% | 0.14% | +31.5% |
| Q3 2020 | $21,024,000 | -4.3% | 444,778 | +2.5% | 0.11% | -13.6% |
| Q2 2020 | $21,974,000 | +145.4% | 433,935 | +116.2% | 0.12% | +123.2% |
| Q1 2020 | $8,954,000 | +114.3% | 200,723 | +130.7% | 0.06% | +180.0% |
| Q4 2019 | $4,179,000 | – | 87,011 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |